Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma
-
Published:2023-06-13
Issue:2
Volume:11
Page:42
-
ISSN:2076-3271
-
Container-title:Medical Sciences
-
language:en
-
Short-container-title:Medical Sciences
Author:
Barsouk Adam1, Aluru John Sukumar2, Rawla Prashanth3ORCID, Saginala Kalyan4, Barsouk Alexander5
Affiliation:
1. Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA 2. Elucid Bioimaging, Boston, MA 02216, USA 3. Parrish Medical Center, Titusville, FL 32796, USA 4. Plains Regional Medical Group Internal Medicine, Clovis, NM 88101, USA 5. Hematologist-Oncologist, Allegheny Health Network, Pittsburgh, PA 15212, USA
Abstract
Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide. With 890,000 new cases and 450,000 deaths annually per GLOBOCAN estimates, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths. In the developing world, the incidence of HNSCC is growing with increasing consumption of tobacco (smoked or chewed), alcohol, and areca nut (betel quid). Alcohol and tobacco have a synergistic effect, with the heavy consumption of both increasing HNSCC risk 40-fold. In developed nations, HPV-related HNSCC surpasses tobacco- and alcohol-related disease. HPV-related HNSCC more commonly affects the oropharynx, hypopharynx, and larynx than the oral cavity, and is associated with a significantly longer median survival (130 months vs. 20 months). Discrepancies in etiology as well as disparities in lifestyle choices and access to healthcare may account for the greater incidence and poorer survival of HNSCC among minority and lower-socioeconomic-status communities in developed nations. Pharmacotherapy and counseling together have been shown to be effective in promoting smoking and alcohol cessation. Education on cancer risk and community engagement have reduced areca nut consumption in Asia as well as in diaspora communities. HPV vaccination, starting at age 11–12 for both sexes, has been shown to reduce the prevalence of high-risk HPV serologies and prevent pre-cancerous lesions of the cervix, vagina, and vulva. As of 2020, 58.6% of eligible adolescents in the US have received the full two-vaccine series. Increased adoption of vaccination, education on safe sex practices, and routine visual oral screening for high-risk patients would curb growing HNSCC incidence in developed nations.
Reference71 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021 2. Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2020). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. 3. Oral cancer in South East Asia;Cheong;Transl. Res. Oral Oncol.,2017 4. Reviewing the epidemiology of head and neck cancer: Definitions, trends and risk factors;Gormley;Br. Dent. J.,2022 5. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration;Fitzmaurice;JAMA Oncol.,2017
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|